微泡
外体
化学
细胞
分子生物学
癌症研究
小RNA
生物化学
医学
生物
基因
作者
Mahlegha Ghavami,Chrysoula Vraka,Virginie Hubert,Helga Schachner,Karsten Bamminger,Marcus Hacker,Renate Kain,Mehdi Forouzandeh Moghadam
出处
期刊:Nanomedicine
[Future Medicine]
日期:2021-03-01
卷期号:16 (7): 553-567
被引量:6
标识
DOI:10.2217/nnm-2020-0408
摘要
Aim: Here, we established a reliable strategy for generation and characterization of targeted radiolabeled exosomes for the detection of HER2-positive cells quantitatively. Materials & methods: Targeted exosomes (T-exos) were radiolabeled by two different radiotracers, [99mTc]Tc-HMPAO or [111In]In-oxine. The labeling efficiency and stability were assessed using exosome exclusive spin columns. HER2-positive and -negative cells were treated with [111In]In-oxine-exosomes after 3 and 24 h. Results: [111In]In-oxine labeling did not change the binding ability and general features of the exosomes. With [111In]In-oxine, 70% labeling efficiency and 78% radiochemical stability over 24 h were achieved. [111In]In-oxine-T-exos showed greater uptake by HER2-positive cells compared with untargeted exosomes. Conclusion: [111In]In-oxine-T-exos could potentially be used as an effective imaging tool for HER2 expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI